Nerve Repair And Regeneration Market: By Product (Biomaterials, and Neurostimulation & Neuromodulation Devices), By Surgery (Direct Nerve Repair/Neurorrhaphy, Nerve Grafting, Stem Cell Therapy, and Neurostimulation & Neuromodulation Surgeries), and Geography

Purchase Option

$ 4400
$ 6600
$ 8900

Nerve Repair And Regeneration Market is anticipated to be valued at USD 6,356.4 Million in 2022 and is expanded to grow at a significant CAGR of 14.3% over 2023-2029. The global nerve repair and regeneration market is being driven by an increase in the prevalence of neurological and epidemic disorders, as well as an increase in the geriatric population that requires nerve repair and regeneration therapy. As a result of social restriction measures, susceptible individuals such as those with dystonic or Parkinson's disease (PD) with deep brain stimulation (DBS) were at a greater risk of chronic stress, and their motor and psychiatric symptoms were reported to deteriorate. Additionally, the availability of several medicines for treating various Central Nervous System (CNS) illnesses, such as Parkinson's disease and Alzheimer's disease, as well as the expanding breadth of applications, are likely to fuel market expansion throughout the projection period. Due to technical breakthroughs and the development of biodegradable polymers that can aid promote spinal stability and fracture healing while reducing hospitalisation, the biomaterials product segment is expected to grow at the quickest CAGR during the projected period. Demand for neurological disorder therapies owing to the increasing incidence and rising awareness regarding the same will drive the market. Moreover, government funding and reimbursement policies and uninterrupted technological advances are projected to boost market growth. Commercialization of goods expected in the coming years as a result of investments by corporations and research organisations is also expected to support market growth. Neurostimulation and neuromodulation surgeries had the highest revenue share of over XX in 2021, based on product. Over the next few years, stem cell therapy is predicted to grow at the fastest rate. The market is expected to increase as a result of various government efforts and approvals to perform clinical studies of biomaterials. In the United States, there are roughly 570 clinics that provide stem cell therapies, and this number is likely to grow, boosting segment growth.

The Nerve Repair And Regeneration Market Key Developments:
  • In March 2022, Integra LifeSciences Holding Corporation a leading global medical technology company and pioneers in nerve repair, announced the launch of NeuraGena 3D Nerve Guide Matrix, a resorbable implant for the repair of peripheral nerve discontinuities. NeuraGen 3D is a nerve repair product specifically engineered to create an optimized environment that may allow for a more complete functional recovery following mid-gap nerve repair when compared to hollow nerve conduits alone.
  • In Jan 2020, Checkpoint Surgical, Inc., the leader in intraoperative nerve repair stimulation technology, has enrolled the first patient in its multi-center clinical study of the company's breakthrough nerve regeneration technology. The patient was enrolled at The Ohio State University, one of four sites actively enrolling patients in the double-blind, randomized clinical trial. Other participating sites include the Medical College of Wisconsin, Northwestern University, and Walter Reed National Military Medical Center. The study is also funded by a Department of Defense Clinical Trial Award to Dr. Amy Moore at The Ohio State University.

Nerve Repair Regeneration Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

14.3%

Largest Market

North America

Fastest Growing Market

Asia-Pacific
Nerve Repair And Regeneration Market Dynamics

One of the key factors propelling market expansion is the rising frequency of chronic neurological illnesses such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis, and multiple system atrophy. Treatment efficiency for neurological illnesses has improved as a result of many technological breakthroughs, which is expected to contribute to market growth. The lengthy product clearance process is expected to stymie the expansion of the nerve repair and regeneration market. Another factor impeding market expansion is a scarcity of competent experts and a lack of information among patients and clinicians about nerve repair and regeneration products and processes. However, the expensive cost of neurostimulator devices, as well as a scarcity of experienced specialists, limit market expansion.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018-2022) and forecast (2023-2029)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup's details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis in addition to recent technology advancements and innovations in the market

Nerve Repair Regeneration Market Segmentation

By Product Type
  • Biomaterials
  • Neurostimulation and Neuromodulation Devices
    • Spinal Cord Stimulation Devices
    • Deep Brain Stimulation Devices
    • Sacral Nerve Stimulation Devices
    • Vagus Nerve Stimulation Devices
    • Gastric Electric Stimulation Devices
By Surgery
  • Direct Nerve Repair/Neurorrhaphy
  • Nerve Grafting
  • Stem Cell Therapy
  • Neurostimulation and Neuromodulation Surgeries
By Geography
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Frequently Asked Questions

2022 is the base year and 2029 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Nerve Repair And Regeneration Market is anticipated to be valued at USD 6,356.4 Million in 2022 and is expanded to grow at a significant CAGR of 14.3% over 2023-2029.

1. Executive Summary
2. Global Nerve Repair and Regeneration Market Introduction
2.1. Global Nerve Repair and Regeneration Market - Taxonomy
2.2. Global Nerve Repair and Regeneration Market - Definitions
2.2.1. By Surgery
2.2.2. By Product
2.2.3. By Region
3. Global Nerve Repair and Regeneration Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Nerve Repair and Regeneration Market Dynamic Factors - Impact Analysis
3.6. Global Nerve Repair and Regeneration Market - Competition Landscape
4. Global Nerve Repair and Regeneration Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Nerve Repair and Regeneration Market, By Surgery, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) 
5.1. Direct Neuropathy
5.1.1. Epineural Repair
5.1.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.1.3. Market Opportunity Analysis
5.1.2. Perineural Repair
5.1.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.2.3. Market Opportunity Analysis
5.1.3. Group Fascicular Repair
5.1.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3.3. Market Opportunity Analysis
5.2. Nerve Grafting
5.2.1. Autografts
5.2.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.1.3. Market Opportunity Analysis
5.2.2. Allografts
5.2.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.2.3. Market Opportunity Analysis
5.2.3. Xenografts
5.2.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.2.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3.3. Market Opportunity Analysis
5.3. Stem Cell Therapy
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Neuromodulation Surgery
5.4.1. External Neuromodulation Surgery
5.4.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.4.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.1.3. Market Opportunity Analysis
5.4.2. Internal Neuromodulation Surgery
5.4.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.4.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.2.3. Market Opportunity Analysis
6. Global Nerve Repair and Regeneration Market, By Product, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) 
6.1. Biomaterials
6.1.1. Nerve Conduits
6.1.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.1.3. Market Opportunity Analysis
6.1.2. Nerve Protectors
6.1.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.2.3. Market Opportunity Analysis
6.1.3. Nerve Wraps
6.1.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3.3. Market Opportunity Analysis
6.1.4. Nerve Connectors
6.1.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.1.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.4.3. Market Opportunity Analysis
6.2. Neuromodulation Surgery Devices
6.2.1. External Neuromodulation Surgery
6.2.1.1. Transcutaneous Electrical Nerve Stimulation
6.2.1.1.1.Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.2.1.1.2.Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.1.1.3.Market Opportunity Analysis
6.2.1.2. Transcranial Magnetic Stimulation
6.2.1.2.1.Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.2.1.2.2.Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.1.2.3.Market Opportunity Analysis
6.2.2. Internal Neuromodulation Surgery
6.2.2.1. Spinal Cord Stimulation
6.2.2.1.1.Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.2.2.1.2.Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.2.1.3.Market Opportunity Analysis
6.2.2.2. Deep Brain Stimulation
6.2.2.2.1.Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.2.2.2.2.Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.2.2.3.Market Opportunity Analysis
6.2.2.3. Sacral Nerve Stimulation
6.2.2.3.1.Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.2.2.3.2.Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.2.3.3.Market Opportunity Analysis
6.2.2.4. Vagus Nerve Stimulation
6.2.2.4.1.Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.2.2.4.2.Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.2.4.3.Market Opportunity Analysis
6.2.2.5. Others
6.2.2.5.1.Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.2.2.5.2.Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.2.5.3.Market Opportunity Analysis
7. Global Nerve Repair and Regeneration Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) 
7.1. North America
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Europe
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Latin America
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Global Nerve Repair and Regeneration Market - Opportunity Analysis Index, By Surgery, Product, and Region, 2023 - 2029
8. North America Nerve Repair and Regeneration Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) 
8.1. Surgery Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
8.1.1. Direct Neuropathy
8.1.1.1. Epineural Repair
8.1.1.2. Perineural Repair
8.1.1.3. Group Fascicular Repair
8.1.2. Nerve Grafting
8.1.2.1. Autografts
8.1.2.2. Allografts
8.1.2.3. Xenografts
8.1.3. Stem Cell Therapy
8.1.4. Neuromodulation Surgery
8.1.4.1. External Neuromodulation Surgery
8.1.4.2. Internal Neuromodulation Surgery
8.2. Product Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
8.2.1. Biomaterials
8.2.1.1. Nerve Conduits
8.2.1.2. Nerve Protectors
8.2.1.3. Nerve Wraps
8.2.1.4. Nerve Connectors
8.2.2. Neuromodulation Surgery Devices
8.2.2.1. External Neuromodulation Surgery
8.2.2.1.1.   Transcutaneous Electrical Nerve Stimulation
8.2.2.1.2.   Transcranial Magnetic Stimulation
8.2.2.2. Internal Neuromodulation Surgery
8.2.2.2.1.   Spinal Cord Stimulation
8.2.2.2.2.   Deep Brain Stimulation
8.2.2.2.3.   Sacral Nerve Stimulation
8.2.2.2.4.   Vagus Nerve Stimulation
8.2.2.2.5.   Others
8.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
8.3.1. USA
8.3.2. Canada
8.4. North America Nerve Repair and Regeneration Market - Opportunity Analysis Index, By Surgery, Product, and Country, 2023 - 2029
8.5. North America Nerve Repair and Regeneration Market Dynamics - Trends
9. Europe Nerve Repair and Regeneration Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) 
9.1. Surgery Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Direct Neuropathy
9.1.1.1. Epineural Repair
9.1.1.2. Perineural Repair
9.1.1.3. Group Fascicular Repair
9.1.2. Nerve Grafting
9.1.2.1. Autografts
9.1.2.2. Allografts
9.1.2.3. Xenografts
9.1.3. Stem Cell Therapy
9.1.4. Neuromodulation Surgery
9.1.4.1. External Neuromodulation Surgery
9.1.4.2. Internal Neuromodulation Surgery
9.2. Product Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.2.1. Biomaterials
9.2.1.1. Nerve Conduits
9.2.1.2. Nerve Protectors
9.2.1.3. Nerve Wraps
9.2.1.4. Nerve Connectors
9.2.2. Neuromodulation Surgery Devices
9.2.2.1. External Neuromodulation Surgery
9.2.2.1.1.   Transcutaneous Electrical Nerve Stimulation
9.2.2.1.2.   Transcranial Magnetic Stimulation
9.2.2.2. Internal Neuromodulation Surgery
9.2.2.2.1.   Spinal Cord Stimulation
9.2.2.2.2.   Deep Brain Stimulation
9.2.2.2.3.   Sacral Nerve Stimulation
9.2.2.2.4.   Vagus Nerve Stimulation
9.2.2.2.5.   Others
9.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.3.1. Germany
9.3.2. UK
9.3.3. France
9.3.4. Spain
9.3.5. Italy
9.3.6. Russia
9.3.7. Rest of Europe
9.4. Europe Nerve Repair and Regeneration Market - Opportunity Analysis Index, By Surgery, Product, and Country, 2023 - 2029
9.5. Europe Nerve Repair and Regeneration Market Dynamics - Trends
10. Asia-Pacific Nerve Repair and Regeneration Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) 
10.1. Surgery Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Direct Neuropathy
10.1.1.1. Epineural Repair
10.1.1.2. Perineural Repair
10.1.1.3. Group Fascicular Repair
10.1.2. Nerve Grafting
10.1.2.1. Autografts
10.1.2.2. Allografts
10.1.2.3. Xenografts
10.1.3. Stem Cell Therapy
10.1.4. Neuromodulation Surgery
10.1.4.1. External Neuromodulation Surgery
10.1.4.2. Internal Neuromodulation Surgery
10.2. Product Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Biomaterials
10.2.1.1. Nerve Conduits
10.2.1.2. Nerve Protectors
10.2.1.3. Nerve Wraps
10.2.1.4. Nerve Connectors
10.2.2. Neuromodulation Surgery Devices
10.2.2.1. External Neuromodulation Surgery
10.2.2.1.1.Transcutaneous Electrical Nerve Stimulation
10.2.2.1.2.Transcranial Magnetic Stimulation
10.2.2.2. Internal Neuromodulation Surgery
10.2.2.2.1.Spinal Cord Stimulation
10.2.2.2.2.Deep Brain Stimulation
10.2.2.2.3. Sacral Nerve Stimulation
10.2.2.2.4.Vagus Nerve Stimulation
10.2.2.2.5.  Others
10.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. ASEAN
10.3.5. Australia & New Zealand
10.3.6. Rest of Asia-Pacific
10.4. Asia-Pacific Nerve Repair and Regeneration Market - Opportunity Analysis Index, By Surgery, Product, and Country, 2023 - 2029
10.5. Asia-Pacific Nerve Repair and Regeneration Market Dynamics - Trends
11. Latin America Nerve Repair and Regeneration Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) 
11.1. Surgery Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Direct Neuropathy
11.1.1.1. Epineural Repair
11.1.1.2. Perineural Repair
11.1.1.3. Group Fascicular Repair
11.1.2. Nerve Grafting
11.1.2.1. Autografts
11.1.2.2. Allografts
11.1.2.3. Xenografts
11.1.3. Stem Cell Therapy
11.1.4. Neuromodulation Surgery
11.1.4.1. External Neuromodulation Surgery
11.1.4.2. Internal Neuromodulation Surgery
11.2. Product Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Biomaterials
11.2.1.1. Nerve Conduits
11.2.1.2. Nerve Protectors
11.2.1.3. Nerve Wraps
11.2.1.4. Nerve Connectors
11.2.2. Neuromodulation Surgery Devices
11.2.2.1. External Neuromodulation Surgery
11.2.2.1.1.Transcutaneous Electrical Nerve Stimulation
11.2.2.1.2.  Transcranial Magnetic Stimulation
11.2.2.2. Internal Neuromodulation Surgery
11.2.2.2.1.Spinal Cord Stimulation
11.2.2.2.2. Deep Brain Stimulation
11.2.2.2.3.  Sacral Nerve Stimulation
11.2.2.2.4. Vagus Nerve Stimulation
11.2.2.2.5.   Others
11.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Argentina
11.3.4. Rest of Latin America
11.4. Latin America Nerve Repair and Regeneration Market - Opportunity Analysis Index, By Surgery, Product, and Country, 2023 - 2029
11.5. Latin America Nerve Repair and Regeneration Market Dynamics - Trends
12. Middle East and Africa Nerve Repair and Regeneration Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) 
12.1. Surgery Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Direct Neuropathy
12.1.1.1. Epineural Repair
12.1.1.2. Perineural Repair
12.1.1.3. Group Fascicular Repair
12.1.2. Nerve Grafting
12.1.2.1. Autografts
12.1.2.2. Allografts
12.1.2.3. Xenografts
12.1.3. Stem Cell Therapy
12.1.4. Neuromodulation Surgery
12.1.4.1. External Neuromodulation Surgery
12.1.4.2. Internal Neuromodulation Surgery
12.2. Product Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Biomaterials
12.2.1.1. Nerve Conduits
12.2.1.2. Nerve Protectors
12.2.1.3. Nerve Wraps
12.2.1.4. Nerve Connectors
12.2.2. Neuromodulation Surgery Devices
12.2.2.1. External Neuromodulation Surgery
12.2.2.1.1.   Transcutaneous Electrical Nerve Stimulation
12.2.2.1.2.    Transcranial Magnetic Stimulation
12.2.2.2. Internal Neuromodulation Surgery
12.2.2.2.1.   Spinal Cord Stimulation
12.2.2.2.2.   Deep Brain Stimulation
12.2.2.2.3.   Sacral Nerve Stimulation
12.2.2.2.4.  Vagus Nerve Stimulation
12.2.2.2.5.  Others
12.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.3.1. Gulf Cooperation Council (GCC) Countries
12.3.2. Israel
12.3.3. South Africa
12.3.4. Rest of MEA
12.4. MEA Nerve Repair and Regeneration Market - Opportunity Analysis Index, By Surgery, Product, and Country, 2023 - 2029
12.5. MEA Nerve Repair and Regeneration Market Dynamics - Trends
13. Competition Landscape 
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Surgery Offerings, Key Developments, Strategies, and SWOT Analysis)
13.2.1. GiMer Medical (Taiwan)
13.2.2. Medtronic PLC (Ireland)
13.2.3. Abbott Laboratories (US)
13.2.4. Collagen Matrix (US)
13.2.5. NeuroSigma (US)
13.2.6. Boston Scientific Corporation (US)
13.2.7. Intergra LifeSciences (US)
13.2.8. Nerve Corp (US)
13.2.9. NeuroPace (US)
13.2.10. AxoGen (US)
13.2.11. KeriMedical (Switzerland)
13.2.12. Polyganics (Netherlands)
13.2.13. Synapse Biomedical (US)
13.2.14. BioWave Corporation (US)
13.2.15. tVNS Technologies GmbH (Germany)
13.2.16. Soterix Medical (US)
14. Research Methodology
15. Key Assumptions and Acronyms
  • Abbott Laboratories
  • Integra Lifesciences Corporation
  • Boston scientific Inc.
  • Axogenic
  • Medtronic plc
  • Checkpoint Surgical
  • Stryker Corporation
  • Synovis Micro Companies Alliance
  • Polyganics
  • OrthoMed, Inc.

Adjacent Markets